Development of the drug candidates with atropisomeric property
Project/Area Number |
15K08030
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Drug development chemistry
|
Research Institution | Teikyo University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
児玉 浩子 帝京大学, 医学部, 講師 (00093386)
|
Research Collaborator |
KANASE Yuki
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 軸不斉 / カルバマゼピン / 光学活性 / ウレア / アミド / 三環性中枢作用薬 |
Outline of Final Research Achievements |
In the course of the research work on the atropisomeric property of urea moiety in the drugs, the physicochemical properties of 4-substituted carbamazepine derivatives were investigated. It was elucidated that the 4-substitution is not effective in reducing the rotations (E/Z) about the N-C1' axes around the outer carbamoyl moiety. However, the atropisomers were isolated with high stereochemical stability, meaning that the 4-substitution reduced the butterfly motion of the tricyclic ring system efficiently. The Cl/CH3-substituted carbamazepine derivatives showed greater inhibitory effects on hNav1.2 Na channel currents compared with carbamazepine, although no difference in the activity between enantiomers was observed.
|
Report
(4 results)
Research Products
(27 results)